Denosumab
Also known as Prolia (us), Denfova (india)
Denosumab injection is used to treat certain cases of osteoporosis (a condition in which the bones become thin and weak and break easily) to treat bone loss in individuals with prostate cancer or breast cancer who are being treated with certain medications that cause bone loss to reduce the risk of…
Based on 30 MLs per month. US $1,743.82 vs India $219.46 per ML.
The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.
- Medicine savings over 6 months
- $274,386
- Estimated travel cost
- − $2,300
- Net savings after travel
- $272,086
Even after travel, you could come out ahead by about $272,086.
Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.
Denosumab is filled about 468.5K times a year under Medicare Part D. At the prices above, that works out to roughly:
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.